Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
Related Questions
How do you decide on treatment modality for ocular surface squamous neoplasia?
What is your approach to incorporating IPL therapy for meibomian gland dysfunction?
How do you predict which patients are most likely to have a positive response to Oxervate?
In cases of failed endothelial keratoplasty with concurrent cataract, do you favor repeat keratoplasty plus lens extraction in the same setting or sequential surgeries?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
How do you approach IOL exchange in a patient who is unhappy after cataract surgery with a premium IOL?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
How do you approach the use of Cequa in eyes with severe corneal thinning from a prior, healed corneal ulcer?
In cataract surgery following penetrating keratoplasty, do you think the use of scleral tunnel incisions versus clear corneal incisions meaningfully influence graft survival or astigmatic stability?
How do you approach recommending ocular exams for asymptomatic candidemic patients considering the discordance between the IDSA and American Academy of Ophthalmology guidelines?
